thiorphan has been researched along with Goldblatt Syndrome in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pham, I | 1 |
| Gonzalez, W | 1 |
| el Amrani, AI | 1 |
| Fournié-Zaluski, MC | 1 |
| Philippe, M | 1 |
| Laboulandine, I | 1 |
| Roques, BP | 1 |
| Michel, JB | 1 |
1 other study available for thiorphan and Goldblatt Syndrome
| Article | Year |
|---|---|
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone; Diuresis; E | 1993 |